12/22
11:03 am
coll
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? [Yahoo! Finance]
12/20
07:19 am
coll
Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)? [Yahoo! Finance]
Low
Report
Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)? [Yahoo! Finance]
12/19
07:37 am
coll
3 Unpopular Stocks We Find Risky [Yahoo! Finance]
Low
Report
3 Unpopular Stocks We Find Risky [Yahoo! Finance]
12/10
07:17 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Medium
Report
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
12/8
06:07 pm
coll
Collegium Pharmaceutical (NASDAQ:COLL) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
12/6
02:21 pm
coll
Collegium Pharmaceutical (COLL): Revisiting Valuation After Fresh Coverage and Ongoing Earnings Outperformance [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical (COLL): Revisiting Valuation After Fresh Coverage and Ongoing Earnings Outperformance [Yahoo! Finance]
11/25
01:49 pm
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
07:31 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/20
05:43 am
coll
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? [Yahoo! Finance]
Low
Report
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? [Yahoo! Finance]
11/19
01:17 pm
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
08:48 am
coll
Collegium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Collegium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/12
08:00 am
coll
Collegium to Participate in Upcoming Investor Conferences
Medium
Report
Collegium to Participate in Upcoming Investor Conferences
11/11
09:26 am
coll
2 Momentum Stocks with Exciting Potential and 1 We Find Risky [Yahoo! Finance]
Low
Report
2 Momentum Stocks with Exciting Potential and 1 We Find Risky [Yahoo! Finance]
11/10
04:28 pm
coll
Collegium Pharmaceutical: Another Solid Quarter [Seeking Alpha]
Medium
Report
Collegium Pharmaceutical: Another Solid Quarter [Seeking Alpha]
11/8
10:14 pm
coll
Organon (OGN) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
Low
Report
Organon (OGN) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
11/8
07:05 pm
coll
A Look at Collegium Pharmaceutical's (COLL) Valuation After Upbeat Q3 Results and Raised Guidance [Yahoo! Finance]
Low
Report
A Look at Collegium Pharmaceutical's (COLL) Valuation After Upbeat Q3 Results and Raised Guidance [Yahoo! Finance]
11/7
11:09 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at Truist Financial Corporation from $45.00 to $48.00. They now have a "buy" rating on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at Truist Financial Corporation from $45.00 to $48.00. They now have a "buy" rating on the stock.
11/7
10:26 am
coll
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook [Yahoo! Finance]
Low
Report
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook [Yahoo! Finance]
11/7
08:07 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at HC Wainwright from $44.00 to $46.00. They now have a "buy" rating on the stock.
Medium
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at HC Wainwright from $44.00 to $46.00. They now have a "buy" rating on the stock.
11/6
07:30 am
coll
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
Medium
Report
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
10/29
08:00 am
coll
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
Medium
Report
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
10/28
08:09 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
10/25
07:36 am
coll
Collegium Pharmaceutical (COLL): Assessing Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical (COLL): Assessing Valuation After Recent Share Price Momentum [Yahoo! Finance]
10/25
07:11 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/23
08:00 am
coll
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
Low
Report
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025